From Prototype to Profit: Commercialization Insights
Tracking companies turning innovation into revenue – and the milestones that matter.
About This Column
Nancy Torres's column, 'From Prototype to Profit: Commercialization Insights,' dives deep into the critical journey companies take from development to market success. Unlike typical financial news, this column focuses on the how – the key milestones like regulatory approvals, strategic partnerships, product launches, and funding rounds that directly enable revenue generation. Nancy provides insightful analysis of companies navigating this complex path, identifying promising ventures and flagging potential pitfalls for investors, industry analysts, and business leaders. She examines a diverse range of industries – from biotech and robotics to retail and REITs – providing a unique perspective on what it really takes to translate innovation into lasting commercial viability. Readers will gain actionable insights into emerging trends and a deeper understanding of the forces shaping the future of business.
Displaying items 421-440 of 775 in total
New Gastroparesis Drug Naronapride Poised for Major Trial Reveal
TheKey Sees 300% ROI by Tackling Home Care's Crippling Turnover
Taiwan Forges AI and Green Future with French Tech Partnership
Applause Taps AI Expert as CTO to Tackle AI's Quality Crisis
AI Cough Monitor Earns CE Mark, Targeting Chronic Respiratory Disease
GCG Taps Media Mogul Gunderson to Launch Fee-Only RIA Powerhouse
AI vs. AI: Why Your Heart Monitor Still Cries Wolf, and How to Fix It
Ratio Raises $115.8M, Deploys AI to End B2B Cash Flow Wars
HackerEarth's AI Interviewer Aims to End Tech Hiring Delays
Sycamore Tree Launches Credit Secondaries Arm Amid Market Boom
Data-Driven Wins: Brands Find Major ROI Amidst Budget Squeezes
Medavie's New Report: A Not-for-Profit Blueprint for Canadian Health
Hilltop Holdings Q1 Call: Investors Eye Resilience Amid Market Volatility
TEMSA Fuels Lithuania's Electric Bus Revolution
Cascades Cuts Outlook Amid Storm of Costs and Inefficiencies
Ceva Splits Leadership, Taps Rival CEO for Aggressive Growth Push
Galt's Healthcare Gambit: A Franchise to Fix Pharma?
JW Advisory Taps Finance Vet for Westward Push Amid M&A Boom
Fortuna Mining Surges on Strong Q1, Eyes Major African Expansion
